Author Archives: 汉普肽团队

NAD+ Peptide: Anti-Aging and Cellular Energy Research Guide

——-|——–|———–|———-| Standard anti-aging 250-500 mg 1-2x weekly 4-8 weeks Higher dose studies 500-1000 mg 1x weekly 4-6 weeks Loading phase 500 mg 2x weekly 2 weeks Maintenance 250 mg Every 2-4 weeks Ongoing Neurological research 500-750 mg 1-2x weekly 8-12 weeks Subcutaneous/Intramuscular Research Dosage Protocol Dosage Frequency Notes Standard research 100-250 mg 2-3x weekly Slower […]

PT-141 (Bremelanotide): Sexual Function Research Peptide Guide

——|——–|———————| Mechanism Central (brain) Peripheral (blood vessels) Target MC3/MC4 receptors PDE5 enzyme Effect Desire + arousal Arousal only Works for women Yes (studied) No Onset 30-60 minutes 30-60 minutes Duration 6-12 hours 4-6 hours PT-141 Research Applications Female Sexual Dysfunction Research The most extensively studied application: Hypoactive Sexual Desire Disorder (HSDD): FDA-approved for premenopausal women […]

Melanotan 2 (MT2): Tanning Peptide Research Guide

—————-|——–|———–|———-| Standard loading 0.5 mg (500 mcg) Once daily 7-10 days Aggressive loading 0.75-1.0 mg Once daily 5-7 days Sensitive subjects 0.25 mg (250 mcg) Once daily 10-14 days Alternative schedule 0.5 mg Every other day 2-3 weeks Maintenance Phase Protocol Dosage Frequency Standard maintenance 0.5 mg 2-3 times per week Minimal maintenance 0.25 mg […]

CJC-1295 vs Ipamorelin: Growth Hormone Peptides Comparison Guide

———–|———-|————| Aging & longevity Strong (IGF-1 elevation) Moderate Body composition Strong (lean mass, fat loss) Moderate-Strong Sleep quality Strong (pulsatile release) Moderate Recovery & repair Strong Moderate Metabolic health Strong Moderate Bone density Moderate-Strong Moderate Cognitive function Emerging research Emerging Cardiac health Research interest Research interest Dosage Protocols for Research Disclaimer: All dosage information is […]

TB-500 (Thymosin Beta-4): Complete Research Peptide Guide

———–|——–|———–|———-| Loading phase 4-5 mg Twice weekly 2-3 weeks Maintenance 2-2.5 mg Once weekly 4-6 weeks Acute injury study 5 mg Every 3-4 days 2-4 weeks Chronic condition 2 mg Once weekly 8-12 weeks Total research cycle typically ranges from 4-12 weeks depending on the study design. Many researchers combine TB-500 with BPC-157 for synergistic […]

BPC-157: The Complete Research Peptide Guide (2026)

———-|————-|———–| General tissue repair 200-500 mcg Once or twice daily Tendon/ligament studies 250-500 mcg Twice daily Gastrointestinal research 200-400 mcg Once daily Local injection studies 100-250 mcg At injury site Research protocols typically run 4-8 weeks, with cycle breaks to study long-term effects. How to Reconstitute BPC-157 Proper reconstitution is essential for research accuracy: Wipe […]

New Advances in Peptide Research in 2026: Focusing on Research Breakthroughs of Molecules Such as Retatrutide

Peptide drugs have become a research hotspot in the pharmaceutical field due to their high targeting and low side effects. Retatrutide, as a triple receptor agonist for GIP/GLP-1/GCGR, has continuously made breakthroughs in metabolic disease research in recent years. The latest clinical data show that its effects in weight management and blood sugar regulation provide […]

Retatrutide: The Triple-Agonist Weight Management Peptide | Hanpro Peptides

Retatrutide Peptide for Sale | High Purity | Factory Supply | Hanpro Peptides What Is Retatrutide? Retatrutide is a triple receptor agonist peptide that targets GLP‑1R, GIPR, and GCGR simultaneously. It supports healthy weight management, metabolic balance, and body composition improvement, making it one of the most advanced peptides in metabolic health research. As a […]

Retatrutide: The Breakthrough Peptide Transforming Weight Management

In recent years, Retatrutide has emerged as a breakthrough in weight management and metabolic health. Unlike traditional weight loss medications, this novel GLP-1, GIP, and glucagon receptor agonist targets multiple pathways in the body to reduce appetite, increase satiety, and improve blood sugar control. Clinical trials have shown that participants using Retatrutide achieved an average […]